Institut Jules Bordet

Institut Jules Bordet company information, Employees & Contact Information

Updated June 2026

Quick answer

Institut Jules Bordet is a Hospitals and Health Care company. It has approximately 851 employees on record. Contact data was last refreshed in June 2026. Find Institut Jules Bordet's verified employee emails, phone numbers, headquarters address, and key decision makers below.

VERSION FRANCAISE Centre multidisciplinaire intégré, unique en Belgique et reconnu internationalement, l’Institut Jules Bordet est un hôpital entièrement consacré aux patients atteints de maladies cancéreuses. Depuis plus de 75 ans, nos équipes proposent aux patients des stratégies diagnostiques et thérapeutiques à la pointe du progrès pour prévenir, dépister et lutter activement contre tous les types de cancers. L’Institut Jules Bordet mène aussi d’importantes activités de recherche menant chaque année à des découvertes majeures et dispense un enseignement universitaire spécialisé de haut niveau. NEDERLANDSE VERSIE Het Institut Jules Bordet is een geïntegreerd multidisciplinair centrum dat uniek is in België en dat internationale erkenning geniet. Het ziekenhuis is volledig gewijd aan de behandeling van kankerpatiënten. Al meer dan 75 jaar bieden onze teams de patiënt de allernieuwste diagnostische en therapeutische strategieën aan om alle types kanker te voorkomen, op te sporen en actief te bestrijden. Het Institut Jules Bordet verricht ook belangrijk onderzoek dat elk jaar baanbrekende ontdekkingen oplevert, en geeft gespecialiseerd universitair onderwijs van topniveau. ENGLISH VERSION The Jules Bordet Institute is an integrated, multidisciplinary centre, unique in Belgium and which enjoys an international reputation. The hospital is devoted entirely to patients affected by cancer. For more than 75 years, our teams have been offering patients leading-edge diagnostic and therapeutic strategies in the prevention, screening and active treatment of all types of cancer. The Jules Bordet Institute also carries out important research activities which every year lead to major discoveries, as well as providing high-level, specialised university training.

Company Details

Employees
851
Address
Rue Meylemeersch 90, Anderlecht,région De Bruxelles-Capitale 1070,belgium
Phone
+32 0 2 541 31 11
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
Website
bordet.be
Keywords
cancer.
HQ
Anderlecht, Région de Bruxelles-Capitale
Looking for a particular Institut Jules Bordet employee's phone or email?

Institut Jules Bordet Questions

News

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer - PNAS

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer PNAS

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment - Frontiers

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment Frontiers

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients | npj Breast Cancer - Nature

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients | npj Breast Cancer Nature

Fortnightly or fractionated weekly docetaxel–cisplatin–5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study - Wiley Online Library

Fortnightly or fractionated weekly docetaxel–cisplatin–5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study Wiley Online Library

CDK 4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib - EMBO Press

CDK 4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib EMBO Press

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer - PNAS

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer PNAS

Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies - Frontiers

Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies Frontiers

Ectopic Fetal Liver Tissue in the Placenta of a Twin Pregnancy: A Case Report and Review of Literature - Wiley Online Library

Ectopic Fetal Liver Tissue in the Placenta of a Twin Pregnancy: A Case Report and Review of Literature Wiley Online Library

Physiological and Clinical Impact of Repeated Inhaled Oxygen Variation on Erythropoietin Levels in Patients After Surgery - Frontiers

Physiological and Clinical Impact of Repeated Inhaled Oxygen Variation on Erythropoietin Levels in Patients After Surgery Frontiers

Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma - PNAS

Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma PNAS

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer - Frontiers

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer Frontiers

Indo-cyanine green administration to identify loss of lymph after axillary lymph node dissection - Frontiers

Indo-cyanine green administration to identify loss of lymph after axillary lymph node dissection Frontiers

Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature - Frontiers

Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature Frontiers

Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT - Frontiers

Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT Frontiers

Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers - Frontiers

Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers Frontiers

Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research - Frontiers

Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research Frontiers

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma - Frontiers

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma Frontiers

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma - Frontiers

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma Frontiers

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders - Frontiers

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders Frontiers

Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far? - Frontiers

Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far? Frontiers

Scintigraphic Investigations of the Deep and Superficial Lymphatic Systems in the Evaluation of Lower Limb Oedema - Nature

Scintigraphic Investigations of the Deep and Superficial Lymphatic Systems in the Evaluation of Lower Limb Oedema Nature

Timing evolution of lobular breast cancer through phylogenetic analysis - The Lancet

Timing evolution of lobular breast cancer through phylogenetic analysis The Lancet

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment - Frontiers

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment Frontiers

An Improved Sequencing-Based Bioinformatics Pipeline to Track the Distribution and Clonal Architecture of Proviral Integration Sites - Frontiers

An Improved Sequencing-Based Bioinformatics Pipeline to Track the Distribution and Clonal Architecture of Proviral Integration Sites Frontiers

PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project - Business Wire

PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project Business Wire

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer - The New England Journal of Medicine

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer The New England Journal of Medicine

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant